Diabetes (medication) and osteoarthritis

Description

Osteoarthritis (OA) is a degenerative disease affecting over 1,500,000 people in the Netherlands making it one of the most prevalent diseases in the country. Moreover, due to the ageing population and the increase of people with overweight its prevalence is expected to rise in the following decades. Although symptomatic treatment options are widely available, currently no disease modifying osteoarthritis drugs (DMOAD) exist. Anti-diabetic medications may offer opportunities for patients with OA. In this project we aim to evaluate the effect of these drugs on the occurrence and development of OA.

Who is the principal investigator?

Dr. Yannick Nielen

Who is collaborating?

Department of Rheumatology MUMC+

Are we looking for students or researchers to collaborate on this project?

We offer short (at least 3 months) and long term (at least 6 months) internships for students with an interest in pharmacoepidemiology, diabetes, and rheumatology (and pharmacy). Experience with programming or coding (e.g. R, SAS, SPSS) is recommended; however, some in-house training is available.
Also, visit our Vacancies page.

Contact for internship or collaboration and general questions

Dr. Yannick Nielen (yannick.nielen@mumc.nl)

Was this page useful?

Good

Sufficient

Insufficient

To help us improve our website we would like to know why you do not find this page useful. You can select more than one reason below and give your opinion.

I find the page too difficult to understand

I can\'t find what I am looking for

I find that the page is too boring

Other reason (fill in below)

Your opinion

Geef uw mening over de website, of vertel ons hoe wij onze website kunnen verbeteren.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.